22.06.2015 Views

Wednesday - ARVO

Wednesday - ARVO

Wednesday - ARVO

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

4509 – 4524 – <strong>Wednesday</strong> – Papers/Minisymposium<br />

<strong>Wednesday</strong> Papers/<br />

Minisymposium<br />

11:00 am – 12:45 pm<br />

4509 — 12:15 Long-Term and Lasting<br />

Outcomes of Combination Treatment for<br />

Age-Related Macular Degeneration with<br />

Photodynamic Therapy and Intravitreal<br />

Injection of Anti-Vascular Endothelial Growth<br />

Factor. Colleen M. McLellan, R. Silva-Garcia, K.<br />

W. Small. Molecular Insight Research Foundation,<br />

Glendale, CA *CR<br />

6E<br />

<strong>Wednesday</strong>, May 08, 2013 11:00 AM-12:45 PM<br />

Retina<br />

426 Macular Disease Other<br />

Than AMD II<br />

Moderators: William F. Mieler and<br />

K. Bailey Freund<br />

4510 — 11:00 Occult Central Serous<br />

Chorioretinopathy. K Bailey Freund 1, 2 , D.<br />

Warrow 3 , R. Gallego-Pinazo 1, 5 , Q. V. Hoang 4 .<br />

1<br />

Ophthalmology, Vitreous Retina Macula<br />

Consultants New York, New York, NY;<br />

2<br />

Ophthalmology, New York University, New<br />

York, NY; 3 Ophthamology, New York Eye and<br />

Ear Infirmary, New York, NY; 4 Ophthalmology,<br />

Columbia University, New York, NY;<br />

5<br />

Ophthalmology, University and Polytechnic<br />

Hospital La Fe, Valencia, Spain *CR<br />

4511 — 11:15 Effect of Somatostatin on the<br />

expression of tight junctions and urokinase<br />

plasminogen activator receptor in human retinal<br />

pigment epithelial cells. Alex Fonollosa 1, 2 , J.<br />

Artaraz 1 , A. Martinez-Berriotxoa 1 , E. Vecino 2 .<br />

1<br />

Ophthalmology, Hospital de Cruces, Portugalete,<br />

Spain; 2 Grupo de Oftalmobiologia Experimental,<br />

Bilbao, Spain<br />

4512 — 11:30 Selective Laser Photocoagulation<br />

of Peripheral Non-perfused Retinal Areas<br />

May Improve the Vision in Patients with<br />

Central Retinal Vein Occlusion Treated with<br />

Ranibizumab. Matus Rehak 1 , A. Franke 2 , P. M.<br />

Wiedemann 1 . 1 Department of Ophthalmology,<br />

University of Leipzig, Leipzig, Germany; 2 Clinical<br />

Trial Centre (ZKS) Leipzig, University of Leipzig,<br />

Leipzig, Germany *CR, f<br />

4513 — 11:45 Macular Bruchs Membrane<br />

Defects and Axial Length: Association with<br />

Gamma Zone and Delta Zone in Peripapillary<br />

Region. Jost B. Jonas 1 , K. Ohno-Matsui 2 ,<br />

R. F. Spaide 3 , L. Holbach 4 , S. Panda-Jonas 1 .<br />

1<br />

Ophthalmology, Medical Faculty Mannheim-<br />

Heidelberg, Mannheim, Germany; 2 Department<br />

of Ophthalmology and Visual Science, Tokyo<br />

Medical and Dental University, Tokyo, Japan;<br />

3<br />

Vitreous-Retina-Macula Consultants of New<br />

York and the LuEsther T. Mertz Retinal Research<br />

Center, Manhattan Eye, Ear, and Throat Hospital,<br />

New York, NY; 4 Department of Ophthalmology,<br />

Friedrich-Alexander University Erlangen-Nürnberg,<br />

Erlangen, Germany *CR<br />

4514 — 12:00 Treatment Experience with<br />

Intravitreal Aflibercept Injection (IAI) After<br />

Switching to PRN Dosing in Patients with<br />

Macular Edema Secondary to Central Retinal<br />

Vein Occlusion (CRVO). David M. Brown 1 , F. G.<br />

Holz 2 . 1 Retina Consultants of Houston, Houston,<br />

TX; 2 Department of Ophthalmology, University of<br />

Bonn, Bonn, Germany *CR, f<br />

4515 — 12:15 Two-Year Results of the<br />

COPERNICUS Study Evaluating Intravitreal<br />

Aflibercept Injection (IAI) for Macular Edema<br />

Secondary to Central Retinal Vein Occlusion<br />

(CRVO). W. Lloyd Clark. Palmetto Retina Center,<br />

West Columbia, SC *CR, f<br />

4516 — 12:30 Eighteen-Month Results of<br />

the GALILEO Study Evaluating Intravitreal<br />

Aflibercept Injection (IAI) for Macular Edema<br />

Secondary to Central Retinal Vein Occlusion<br />

(CRVO). Yuichiro Ogura 1 , J. Korobelnik 2 , J.<br />

Roider 3 , R. Vitti 4 , F. G. Holz 5 , F. Hiemeyer 6 , B.<br />

Stemper 6 , O. Zeitz 6 , R. Sandbrink 6 . 1 Department<br />

of Ophthalmology, Nagoya City University<br />

Medical School, Nagoya, Japan; 2 Department<br />

of Ophthalmology, CHU Bordeaux, Universite<br />

Bordeuax, Bordeaux, France; 3 Department of<br />

Ophthalmology, University Medical Center<br />

Schleswig-Holstein, Kiel, Germany; 4 Regeneron<br />

Pharmaceuticals Inc., Tarrytown, NY; 5 Department<br />

of Ophthalmology, University of Bonn, Bonn,<br />

Germany; 6 Bayer Healthcare, Berlin, Germany<br />

*CR, f<br />

606/607<br />

<strong>Wednesday</strong>, May 08, 2013 11:00 AM-12:45 PM<br />

Immunology/Microbiology<br />

427 Ocular Immune Responses<br />

Moderators: Holly L. Rosenzweig and<br />

Thomas Langmann<br />

4517 — 11:00 Loss of MicroRNA-124<br />

and MicroRNA-126 expression regulates<br />

inflammatory microglial activation in inherited<br />

retinal degeneration. Thomas Langmann 1, 2 , C.<br />

Moehle 3 , M. Karlstetter 1 , B. H. Weber 2 . 1 Department<br />

of Ophthalmology, University of Cologne, Cologne,<br />

Germany; 2 Institute of Human Genetics, University<br />

of Regensburg, Regensburg, Germany; 3 Center of<br />

Excellence for Fluorescent Bioanalytics, University<br />

of Regensburg, Regensburg, Germany<br />

4518 — 11:15 Mice lacking TNFR1 develop<br />

less angiogenesis during late stage experimental<br />

autoimmune uveoretinitis (EAU). Madeleine<br />

Stimpson 1 , J. Liu 1 , D. A. Copland 1 , T. K. Khera 1 ,<br />

A. D. Dick 1, 2 . 1 Academic Unit of Ophthalmology,<br />

University of Bristol, Bristol, United Kingdom;<br />

2<br />

Cellular and Molecular Medicine, University of<br />

Bristol, Bristol, United Kingdom *CR<br />

4519 — 11:30 Differential effects of TLR-<br />

3 activated RPE on retinal microglia and<br />

blood-derived monocytes. Alexa K. Klettner 1 ,<br />

T. Hamann 1 , S. Wilker 1 , C. Berg 1 , K. Schlüter 1 , R.<br />

Lucius 2 , M. Rolf 2 , J. Roider 1 . 1 Ophthalmology, Univ<br />

of Kiel, Kiel, Univ Medical Center, Kiel, Germany;<br />

2<br />

Anatomy, University of Kiel, Kiel, Germany *CR<br />

4520 — 11:45 Demonstration of Donor T cell<br />

Recruitment and Correlation with Inflammatory<br />

Cytokine Presence in Experimental Ocular<br />

Graft-versus-Host Disease. Samantha Herretes 1 ,<br />

J. C. Murillo 1 , D. Ross 2 , H. Barreras 2 , Y. Tan 1 , A. M.<br />

Saeed 1 , A. Gonzalez 1 , C. Betancurt 1 , R. B. Levy 2 , V.<br />

L. Perez 1, 2 . 1 Ophthalmology, Bascom Palmer Eye<br />

Inst, Univ of Miami, Miami, FL; 2 Immunology and<br />

Microbiology, University of Miami, Miami, FL *CR<br />

4521 — 12:00 Monophasic PDSAg-induced<br />

EAU dominates over relapsing R14-induced<br />

EAU. Ulrike Kaufmann, M. Diedrichs-Möhring,<br />

G. Wildner. Ophthalmology, Clinic of the Ludwig-<br />

Maximilians-University, Munich, Germany<br />

4522 — 12:15 Inhibition of Vascular<br />

Endothelial Growth Factor Ameliorates Ocular<br />

Allergy in the Murine Model. Daniel R. Saban 1 ,<br />

R. Dana 2 , H. Lee 2 , T. Blanco 1 . 1 Ophthalmology,<br />

Duke University School of Medicine, Durham, NC;<br />

2<br />

Ophthalmology, Schepens Eye Res Inst, Mass. Eye<br />

& Ear, Harvard Medical School, Boston, MA *CR<br />

4523 — 12:30 Translational Modeling of<br />

Calpain-5 Vitreoretinopathy Mechanisms<br />

in Mice. Vinit B. Mahajan 1, 2 , K. J. Wert 3 , J. M.<br />

Skeie 1, 2 , S. H. Tsang 4 . 1 Ophthalmology, University<br />

of Iowa, Iowa City, IA; 2 Omics Laboratory,<br />

University of Iowa, Iowa City, IA; 3 Institute of<br />

Human Nutrition, Columbia University, New York,<br />

NY; 4 Ophthalmology, Columbia University, New<br />

York, NY<br />

608<br />

<strong>Wednesday</strong>, May 08, 2013 11:00 AM-12:45 PM<br />

Anatomy/Pathology<br />

428 Uveal Melanoma: Experimental<br />

Therapeutics<br />

Moderators: Hans Grossniklaus, Sarah E.<br />

Coupland and Arun D. Singh<br />

4524 — 11:00 Microphthalmia-associated<br />

transcription factor (MITF) and Steroid<br />

Receptor Coactivator (SRC)-3 cooperate to<br />

promote proliferation, survival and metabolism<br />

in Gα-mutant uveal melanoma (UM) cells.<br />

Vassiliki Poulaki 1, 2 , S. Chew 3, 4 , B. He 3, 4 , V.<br />

Eedunuri 5 , M. M. Jager 6 , B. W. O’Malley 4 ,<br />

N. Mitsiades 3, 4 . 1 Ophthalmology, Boston VA<br />

Healthcare System, Boston, MA; 2 Ophthalmology,<br />

Boston University, Boston, MA; 3 Medicine,<br />

Baylor College of Medicine, Houston, TX;<br />

4<br />

Molecular and Cellular Biology, Baylor College<br />

of Medicine, Houston, TX; 5 Adrienne Helis Malvin<br />

Medical Research Foundation, New Orleans, LA;<br />

6<br />

Ophthalmology, Leiden University Medical Center,<br />

Leiden, Netherlands<br />

The Commercial Relationships (CR) Index for Disclosures and the Clinical Trial (CT) Registration Index are at arvo.org/2013/ProgramSummary/Index.<br />

294

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!